10x Genomics (TXG) Other Non Operating Income (2018 - 2026)

10x Genomics (TXG) has 9 years of Other Non Operating Income data on file, last reported at -$815000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income fell 138.16% year-over-year to -$815000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.9 million (down 273.22% YoY), and the FY2025 full-year result was $1.0 million, up 149.83% from the prior year.
• Other Non Operating Income advanced to -$815000.0 in Q1 2026, from -$2.5 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $4.0 million in Q4 2022 to a low of -$3.0 million in Q4 2024.
• A 5-year average of -$137411.8 and a median of -$1.0 million in 2024 frame the typical range for Other Non Operating Income.
• Peak annual rise in Other Non Operating Income reached 79800.0% in 2022, while the deepest fall reached 453.74% in 2022.
• Tracing TXG's Other Non Operating Income over 5 years: stood at $4.0 million in 2022, then dropped by 0.33% to $4.0 million in 2023, then plunged by 176.57% to -$3.0 million in 2024, then grew by 16.56% to -$2.5 million in 2025, then soared by 67.96% to -$815000.0 in 2026.
• Business Quant data shows TXG's Other Non Operating Income at -$815000.0 in Q1 2026, -$2.5 million in Q4 2025, and -$1.2 million in Q3 2025.